Allianz Asset Management
TGTX icon

Allianz Asset Management’s TG Therapeutics TGTX Stock Holding History

Allianz Asset Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,100
Closed -$280K – 2292
2025
Q1 		$280K Sell
7,100
-15,100
-68% -$508K ﹤0.01% 2057
2024
Q4 		$668K Sell
22,200
-7,700
-26% -$221K ﹤0.01% 1771
2024
Q3 		$699K Buy
+29,900
New +$653K ﹤0.01% 1760
2022
Q2 		– Sell
-207,025
Closed -$1.97M – 2414
2022
Q1 		$1.97M Sell
207,025
-72,181
-26% -$835K ﹤0.01% 1597
2021
Q4 		$5.31M Buy
279,206
+4,837
+2% +$126K ﹤0.01% 1206
2021
Q3 		$9.13M Buy
274,369
+43,394
+19% +$1.34M 0.01% 1053
2021
Q2 		$8.96M Buy
230,975
+94,514
+69% +$3.71M 0.01% 902
2021
Q1 		$6.58M Buy
136,461
+13,040
+11% +$627K 0.01% 971
2020
Q4 		$6.42M Sell
123,421
-27,453
-18% -$928K 0.01% 976
2020
Q3 		$4.04M Buy
150,874
+17,417
+13% +$401K ﹤0.01% 1048
2020
Q2 		$2.6M Buy
133,457
+25,621
+24% +$413K ﹤0.01% 1503
2020
Q1 		$1.06M Sell
107,836
-39,055
-27% -$493K ﹤0.01% 1774
2019
Q4 		$1.63M Buy
+146,891
New +$1.12M ﹤0.01% 1965
2018
Q4 		– Sell
-169,628
Closed -$950K – 2700
2018
Q3 		$950K Buy
169,628
+14,316
+9% +$164K ﹤0.01% 2240
2018
Q2 		$2.04M Sell
155,312
-899
-0.6% -$12.4K ﹤0.01% 1935
2018
Q1 		$2.22M Buy
156,211
+18,231
+13% +$233K ﹤0.01% 1876
2017
Q4 		$1.13M Buy
137,980
+8,602
+7% +$75.2K ﹤0.01% 2204
2017
Q3 		$1.53M Buy
129,378
+4,530
+4% +$51.6K ﹤0.01% 2099
2017
Q2 		$1.25M Buy
+124,848
New +$1.4M ﹤0.01% 2136

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Allianz Asset Management's TGTX Position: Q2 2025 in Review

Allianz Asset Management sold out of TG Therapeutics (TGTX) in Q2 2025, closing a stake of 7,100 shares — an estimated $280K sold.

Allianz Asset Management first reported a position in TGTX in Q2 2017 and held it in 19 quarters. The position peaked at $9.13M in Q3 2021. 356 funds tracked by Wall St. Rank hold TGTX as of Q2 2025.

  • Allianz Asset Management reported no remaining TG Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Allianz Asset Management sold 7,100 TG Therapeutics shares in Q2 2025, an estimated $280K.
  • Allianz Asset Management first reported a position in TG Therapeutics in Q2 2017 and held it in 19 quarters.
  • Allianz Asset Management's TG Therapeutics position peaked at $9.13M in Q3 2021.
  • 356 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2025.

Based on Allianz Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.